Friday - March 29, 2024
Harvard School of Public Health: A Versatile Vessel for Next-Gen Therapeutics
July 23, 2020
CAMBRIDGE, Massachusetts, July 23 -- Harvard University's T.H. Chan School of Public Health issued the following news release:

Harvard University's Office of Technology Development (OTD) and the Harvard T.H. Chan School of Public Health announced the launch of Vesigen Therapeutics, a startup company that aims to overcome the challenge of delivering next-generation therapeutics, such as gene-editing complexes, RNA molecules, and other large proteins, to intracellular targets in speci . . .

Targeted News Service Document Request Form

This document is available to you by e-mail if you complete the form below with relevant information. There may be a fee for this article or ongoing service of similar materials. We will be in touch shortly.

Name:
What's your
Affiliation
Government Newspaper / Media Business
Public Policy Individual / Student Educators
Email:
Phone:
Organization, if any:
State/Country you are in:
Additonal questions
or comments:

Click here for more information about our products

Click here for more information about our products